Published on:

New research questions FDA’s decision to keep Avandia on the market

A new study published in the Journal of the American Medical Association has confirmed and corroborated the results of an earlier study that first connected Avandia to an increased risk of heart attack. This new study used a different methodology than the earlier study published in the New England Journal of Medicine, and it reached the same conclusion – a patient’s risk of heart attack increases by over forty percent when taking the diabetes medication, Avandia. This statistic is further exacerbated by the fact that diabetes sufferers are already at a higher risk of heart attack. In fact, the leading cause of death for diabetes sufferers is heart attack. It is this heightened risk to heart attack that has the researchers behind the new study to state that the FDA should reconsider its latest decision to keep the drug on the market.

Click here for the full article